Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated Nebivolol for improving endothelial dysfunction in African Americans with hypertension; results were posted in December 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: Emory University | Conditions: High Blood Pressure | Phase 4 | Status: COMPLETED | Results posted: 2014-12-19